Skip to main content

2022 4th MPWRM Resource Center Annual Stakeholder’s Summit

April 18 – 19, 2022 | Virtual Meeting

As a follow-on to December 2021 DOCTRC session on Critical Considerations in Preclinical Product Development, this year’s Annual Stakeholder’s Summit focused on building a compelling pitch deck.  Day 1 included updates from the Resource Center and presentations by the ITP teams, and day 2 comprised of 2 keynote talks and mini-sessions on components of a compelling pitch deck, followed by a breakout discussion.

Event agenda:

April 18, 2022 (Day 1)

  • ITP Progress Updates
  • ITP teams: Stakeholder Listening Sessions
  • Closed door session: MPWRM Resource Center business

April 19, 2022 (Day 2)

  • Keynote Presentation: Fundraising for Advancing your DOC Technology Towards Commercialization and Successful Clinical Adoption
  • Critical Considerations in Preclinical Product Development, II: Building a Compelling Pitch Deck
    • Session 1: Regulatory Strategies
    • Session 2: Market Assessment
    • Session 3: User Handling Trials
  • Breakout Session: Building a Compelling Pitch Deck
  • Closed door session: MPWRM Resource Center business

Welcome Remarks | April 18, 2022 (Day 1)

  • Lillian Shum, PhD | Director, Division of Extramural Research, NIDCR
Watch on YouTube: “Michigan Pittsburgh Wyss Regenerative Medicine Resource Center Updates April 18, 2022”

Keynote Presentation: Attracting and Preparing for Investor Meetings Successful Fundraising Presentations and Strategies: Point to Consider | April 19, 2022 (Day 2)

  • Gene Dorff | Chief Executive Officer | Solmetex, LLC
  • Marty Dymek | CEO | Navigate Surgical Technologies USA, Inc.
Watch on YouTube: “Michigan Pittsburgh Wyss Regenerative Medicine Resource Center Keynote Presentations April 18, 2022”

Considerations in Preclinical Product Development, II: Building a Compelling Pitch Deck | April 19, 2022 (Day 2)

  • Session 1: Regulatory Strategies | Kay Fuller (MRDS LLC)/ ITP Panel: Emergence Dental/nanoMag, Luiz Bertassoni/ Pamela Yelick
  • Session 2: Market Assessment | Francine Berkey (The Avenues Company)/ ITP Panel: Will Giannobile, Juan Taboas/ Herb Ray
  • Session 3: User Handling Trials | Jeanne Ambruster (The Avenues Company)/ ITP Panel: Ostiio, RevBio
Watch on YouTube: “Preclinical Development to Enable Clinical Studies What Does FDA Require”